Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla C Dubinsky

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
The Lancet. Gastroenterology & Hepatology|January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Inflammatory Bowel Diseases|June 3, 2024
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter ExperienceOren Ledder, Michael Dolinger, Marla C Dubinsky, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2022
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trialYaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 1, 2026
Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paperDan Turner, Amit Assa, Mikkel Malham, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|September 3, 2010
Real-time tool to display the predicted disease course and treatment response for children with Crohn's diseaseCorey A Siegel, Lori S Siegel, Jeffrey S Hyams, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
The Lancet. Gastroenterology & Hepatology|January 13, 2022
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectivesKonstantinos Papamichael, Waqqas Afif, David Drobne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Inflammatory Bowel Diseases|June 3, 2024
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter ExperienceOren Ledder, Michael Dolinger, Marla C Dubinsky, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2022
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trialYaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 1, 2026
Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paperDan Turner, Amit Assa, Mikkel Malham, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|September 3, 2010
Real-time tool to display the predicted disease course and treatment response for children with Crohn's diseaseCorey A Siegel, Lori S Siegel, Jeffrey S Hyams, et al.
Pageof 29